Pfizer CEO Albert Bourla (L) speaks in the White House as Medicare and Medicaid Administrator Mehmet Oz and US President Donald Trump look on during an announcement on reducing prescription drug prices

Pfizer CEO Albert Bourla (L) speaks in the White House as Medicare and Medicaid Administrator Mehmet Oz and US President Donald Trump look on during an announcement on reducing prescription drug prices

The Trump administration on Tuesday announced a deal granting Pfizer a three-year reprieve on planned tariffs as the pharmaceutical giant vowed to voluntarily lower the prices of unspecified drugs for US purchase.

President Donald Trump, flanked by top health officials, was scant on details regarding what or how many drugs were included in the agreement, the announcement of which came as Washington faced a looming government shutdown.

Originally published on doc.afp.com, part of the BLOX Digital Content Exchange.